---
title: "Medical Product Marketing Firm Yidiantong Receives Equity from Kaixian Capital"
author: "Unique Research"
sourcePublication: "Unique Research (FFCAP English library)"
originalPublishedAt: "2022-07-04T18:30:52+08:00"
canonical: "https://ffcap.cn/en/research/20220704a08yiw00"
source: "https://ffcap.cn/en/research/20220704a08yiw00"
language: "en"
cnSourceUrl: "https://view.inews.qq.com/a/20220704A08YIW00"
---

# Medical Product Marketing Firm Yidiantong Receives Equity from Kaixian Capital

_Unique Research · Company / Funding · July 4, 2022_

On **Jun 28, 2022**, medical product marketing firm **Yidiantong (医点通)** (founded 2015) received equity from **Kaixian Capital** — 4th round — for academic-event promotion and platform upgrades. Digital marketing for pharma/device firms; international clinician advisors; dual-track localization of global medtech. Affiliated VC Xinzhaoyuan incubates early life-science; focus cardio/neuro, oncology, AI, medical robotics. Smart medical-conference platform; hundreds of events/year; >1M doctor + 500k pharma-staff tagged DB. Controller Wen Yaxin 54.8%.

— END —

---

Editorial English edition published on UniqueCapital: https://ffcap.cn/en/research/20220704a08yiw00
On-site reading page: https://ffcap.cn/en/research/20220704a08yiw00